UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Global alliance project with Novo Nordisk opens in Korea
by Marian Chu
2017-09-18 17:14
Pharmaceutical industry leading new growth in Korea: report
by Nam Doo-hyun
2017-09-18 14:50
Opdivo adds one more melanoma indication
by Marian Chu
2017-09-18 11:34
Korean pharmaceuticals challenge Pfizer’s Viviant with combination drugs
by Lee Hye-seon
2017-09-18 11:26
HIRA’s drug pricing allegedly favors Green Cross, PMG Korea
by Song Soo-youn
2017-09-15 17:58
라인
Kolon uses Invossa to attract foreign patients
by Lee Hye-seon
2017-09-15 17:49
SK Chemicals’ release of test result abroad raises curiosity
by Lee Hye-seon
2017-09-15 17:39
Hanmi releases research result of new bio drug in Europe
by Lee Hye-seon
2017-09-15 14:32
LG Chem promotes antidiabetic Zemiglo in Europe
by Lee Hye-seon
2017-09-15 11:51
In historic move, FDA approves 1st biosimilar to treat cancer
by Marian Chu
2017-09-15 11:40
라인
Huons to build new office
by Lee Han-soo
2017-09-15 10:29
Daewoong wins rights to market hepatitis B treatment
by Constance Williams
2017-09-14 19:37
NOAC race: Pradaxa prescription numbers fall behind fast followers
by Marian Chu
2017-09-14 19:02
Opdivo vs. Keytruda - which will doctors choose?
by Marian Chu
2017-09-14 17:54
Chong Kun Dang enters an osteoporosis therapy market
by Lee Hye-seon
2017-09-14 17:53
라인
AstraZeneca regains momentum with positive Imfinzi results
by Marian Chu
2017-09-14 13:34
Amgen, Chong Kun Dang to sell osteoporosis drug in Korea
by Marian Chu
2017-09-13 18:33
Alvogen Korea to sell Vivus’ obesity drug
by Marian Chu
2017-09-13 18:16
ASEAN officials visit JW’s manufacturing plant
by Song Soo-youn
2017-09-13 18:07
Opdivo’s expanded indications ease cancer patients’ worries
by Marian Chu
2017-09-13 16:57
-
이전
111
112
113
114
115
116
117
118
119
120
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top